Pulling SEC filings + quote and writing the call…
TNDM
TANDEM DIABETES CARE INC
Next earnings Aug 4, 2026 (after close) · consensus $-0.33 EPS, $260M rev
Last earnings +2.4% on 2026-05-07
$15.30
▼ -0.65%$15.30▼ -23.65%
over 1Y
L $10.12EODHDH $28.26
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today-0.6%
1W-3.2%
1M+10.4%
3M-37.9%
YTD-29.0%
1Y-23.7%
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 29 analysts
Buy
Revenue grew 7.9% YoY; but unprofitable (net margin -20.2%).
TANDEM DIABETES CARE INC shows $1.01B in FY2025 revenue (+7.9% YoY), a -20.2% net margin, and -131.9% ROE.
Sources: SEC EDGAR (CIK 0001438133, latest 10-Q filed 2026-05-07) · EODHD · as of 6/22/2026, 12:16:44 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.